Back to Conference page
The 13th World Conference on Tobacco OR Health
Building capacity for a tobacco-free world
July 12-15, 2006, Washington, DC, USA
Objective: to evaluate the effectiveness of different therapeutic modalities for smoking cessation.
Methods: 06 months after the four sessions of group behavioral therapy, with or without pharmacotherapy use, all patients were evaluated by phone interview to know the tobacco abandonment index. To compare the different methods, we used the t Studend test, and we considered statistically significant „T 0,05.
Results: between January 2003 and January 2004, 374 patients were treated (68,4% women) in groups, during four weekly sessions. Depending on the therapeutic modality, these patients were divided into four groups: Group I: behavioral therapy (BT) Group II: BT + nicotine replacement therapy (NRT) Group III: BT + bupropion (B) (300 mg/day) Group IV: BT + NRT + B At the end of the four sessions, stopped smoking: 25% of group I, 60% of group II, 68% of group II, 90,7% of group IV. After six months, returned to smoke: 43,6% of group I, 50% of group II. 22,9% of group II and 15,6% of group IV.
Conclusions: the combination of behavioral therapy associated to nicotine replacement therapy plus bupropion war more effective than the others therapeutics modalities and should be offered to all smokers who really want to quit.